Advisory Council on the Implementation of National Pharmacare Biographies

On this page:

Figure #. Text version below.

The Advisory Council on the Implementation of National Pharmacare: (Left to right) Mia Homsy, Vice-Chair; John Wright; Vincent Dumez; Camille Orridge; Dr. Eric Hoskins, Chair; Hon. Diana Whalen; Dr. Nadine Caron.

Biographies

Eric Hoskins, Chair

Dr. Hoskins served in the Ontario government as Minister of Health and Long-Term Care from June 2014 to February 2018. He was previously Ontario’s Minister of Economic Development, Trade and Employment, Minister of Children and Youth Services, and Minister of Citizenship and Immigration. Dr. Hoskins represented the riding of St. Paul’s as Member of Provincial Parliament from 2009-2018.

Dr. Hoskins is a renowned humanitarian, physician, public health specialist, and a proud Canadian with a long and dedicated record of public service.

After finishing his medical studies at McMaster University, and subsequently at Oxford University as a Rhodes Scholar, Dr. Hoskins spent nearly a decade as a doctor and humanitarian in war-torn regions in Africa and around the world. From 1997 to 2000, he served as senior policy advisor to then Foreign Minister Lloyd Axworthy on issues such as human rights, child soldiers, peacekeeping and the landmines ban.

He and his wife, Dr. Samantha Nutt, founded the international charity War Child Canada to help hundreds of thousands of children in war-affected regions across the globe. Dr. Hoskins was also Advisor to the Office of the Special Representative for Children and Armed Conflict at the United Nations.

Dr. Hoskins has been recognized for his humanitarian work and public service. In 2008, he was invested as an Officer of the Order of Canada. He has also received the Governor General’s Meritorious Service Cross, and has been awarded the United Nations Lester B. Pearson Peace Medal.

Mia Homsy, Vice-Chair

Ms. Homsy is Director General of the Institut du Québec, a socio-economic research institute stemming from a partnership between the Conference Board of Canada and HEC Montréal. As part of this organization, Ms. Homsy assists in guiding the development of better public policies in Quebec, particularly with respect to competitiveness and economic development.

Ms. Homsy has previously worked as a political attaché in the office of the Minister of Economic Development of Quebec, Minister of Tourism and Minister responsible for the Montreal region. Ms. Homsy has also held the positions of political advisor and Deputy Chief of Staff in the offices of the Minister of Finance of Quebec and the Minister of Revenue of Quebec.

Ms. Homsy is a graduate of International Studies from the Université de Montréal and holds a Master’s in International Management from HEC Montréal. 

Nadine Caron

Dr. Caron currently resides in Prince George, British Columbia, where she provides surgical oncology care for those that call rural and remote Canada home. Dr. Caron is also Co-Director of the University of British Columbia’s (UBC) Centre for Excellence in Indigenous Health and an Associate Professor of the Faculty of Medicine’s Department of Surgery where she teaches in the Northern Medical Program.

Dr. Caron has served on numerous committees including the Rural Surgery Committee of the Canadian Association of General Surgeons, the Board of Directors of the Michael Smith Foundation for Health Research, the Board of Directors of the Canadian Heart and Stroke Foundation and the Governing Council of the Canadian Institutes of Health Research.

Dr. Caron holds an undergraduate degree from Simon Fraser University in kinesiology and a medical degree from UBC. During her surgical residency, she completed a Master’s in Public Health from Harvard University and was awarded UBC's Top Student Award.    

Vincent Dumez

Mr. Dumez is Co-director of the Centre of Excellence on Partnership with Patients and the Public at the Faculty of Medicine of the Université de Montréal. He also sits on the Board of Directors for the Canadian Foundation for Healthcare Improvement.

Suffering from severe chronic diseases for more than three decades, Mr. Dumez has been actively involved in the promotion of the ‘patient partner’ concept. This involvement has come forward through his work on various boards of community organizations and his involvement as a speaker in national and international forums addressed to healthcare professionals.

Mr. Dumez has worked on numerous projects related to patient engagement for institutions such as the Ministry of Health and Social Services of Quebec, the Canadian Institutes of Health Research, and the National Institute for Excellence in Health and Social Services.

Mr. Dumez holds a finance degree and a Master’s in Science of Management from HEC Montréal.

Camille Orridge

Ms. Orridge is a Senior Fellow at Wellesley Institute, a research and policy organization that seeks to improve health and health equity in the Greater Toronto Area.

Ms. Orridge is a passionate advocate for social change and health equity. While at the Toronto Central Local Health Integration Network, Ms. Orridge launched Language Services Toronto, a telephone interpretation service for non-English speaking patients of Toronto’s hospitals. As Chief Executive Officer of the Toronto Central Community Care Access Centre, she also worked to better serve Toronto’s aging and diverse population through strengthening the community health sector.

In 2012, Ms. Orridge was among the top 25 Women of Influence in Health and in 2011, she was awarded the Health Equity Council Woman of Distinction Award. In 2014, she received the Excellence in Medicine Award from the African Canadian Achievement Awards.

Ms. Orridge holds a Master’s in Health Administration from the University of Toronto.

Diana Whalen

The Honourable Diana Whalen was Deputy Premier of Nova Scotia from 2013 to 2017.

She was first elected to the Nova Scotia House of Assembly for Halifax Clayton Park in 2003 and was re-elected in 2006, 2009, and again in 2013.

Between 2013 and 2015 she served as Nova Scotia’s Minister of Finance and Treasury Board, the Minister responsible for the Nova Scotia Liquor Corporation and the Minister responsible for the Utility and Review Board Act. She later served as Minister of Justice and the Attorney General from 2015 to 2017.

Ms. Whalen is a former Halifax Regional Municipality Councillor and worked for fifteen years as a management consultant. She lived and worked in Korea, Australia and Jamaica for eight years in her early career.

An active volunteer, she was recognized for her work in the community with the Women of Distinction Award in 2009 by the Canadian Progress Club Halifax Citadel.

Ms. Whalen is currently the Interim Vice-President (Administration) at Mount Saint Vincent University. She holds a Bachelor of Arts and a Master’s in Business Administration, both from Dalhousie University and is also a Chartered Professional Accountant (CPA, CMA).

John Wright

Mr. Wright is a former Deputy Minister of Health and Deputy Minister of Finance for the Government of Saskatchewan.

Mr. Wright has 35 years of public-sector experience. In April 1995, he was appointed President and Chief Executive Officer of Saskatchewan Government Insurance and in July 1996 became President and Chief Executive Officer of Crown Investments Corporation. Mr. Wright has also served as President of SaskPower.

In 2010, Mr. Wright was selected as President and Chief Executive Officer of the Canadian Institute for Health Information.

Mr. Wright holds an Honours Bachelor in Economics from the University of Western Ontario and a Master’s in Economics from the University of Alberta. He is presently a lecturer in economics at the University of Regina.

Summary of Affiliations and Interests

Purpose

External Advisory Bodies (EAB) provide Health Canada and the Minister of Health with expert advice from individuals who have valuable knowledge, expertise or experience. The table below summarizes the affiliations and interests relevant to the Advisory Council on the Implementation of National Pharmacare as declared by the Council Members. Health Canada considers these declarations a part of the appointment process.

This summary is made available as part of Health Canada’s commitment to transparency regarding the membership of its advisory bodies. The Council Members are expected to report promptly any changes in their circumstances as reported on their Affiliations and Interests Declaration Form.

Declaration of affiliations and interests

The Council members must declare the following:

1. Direct financial interests

Do you, your spouse/partner, or dependent minor child have any direct financial interests that are of relevance to the mandate of the advisory body, including current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares, or bonds? 

2. Indirect financial interests

2.1 Within the past five years, have you or your spouse/partner received payment for work done or being done, or financial support, from a party that has an interest in the mandate of the advisory body? Including past employment, contracts or consulting, research support, personal education grants, contributions, fellowships, sponsorships, and honoraria for teaching, speaking, or writing engagements.

2.2 Within the past five years, have you or your spouse/partner received materials, discounted products, gifts, or other benefits, or attended conferences or meetings where all or part of the travel and accommodation costs were provided by a party that has an interest in the mandate of the advisory body?

2.3 Within the past five years, have any of the organizations where you or your spouse/partner are currently employed or where you or your spouse/partner participate in internal decision making (that is, as a board member or as an executive or non-executive director) received grants or other funding from a party that has an interest in the mandate of the advisory body?

3. Intellectual interests

3.1 Within the past five years, have you provided any formal advice or opinion to industry; a Canadian federal, provincial, or municipal government; a foreign government; or a non-government organization on a matter of relevance to the mandate of the advisory body? Including expert testimony or acting as witness (full or part-time), participation on an advisory body, and so on.

3.2 Have you ever made public a statement (speeches, lobbying, and so on) or publicly stated a point of view (including in scientific papers, articles, journals, or other publications, or on websites) on issues of relevance to the advisory body’s mandate?

3.3 Do you currently have any professional or volunteer affiliations (such as membership in professional/scientific societies, trade associations, lobbying, public interest, or advocacy groups) that may have an interest in the mandate and work of this advisory body? 

4. Other

Do you or your spouse/partner have any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable apprehension or grounds for concern regarding the integrity and objectivity of your participation in this advisory body?

Summary of Council Member responses
Name Summary of Responses
Direct
Financial Interest
Indirect Financial Interest Intellectual Interest Other
Dr. Eric Hoskins 1.
No
2.1
No
2.2
No
2.3
No
3.1
Yes
3.2
Yes
3.3
No
4.
No

Comments:

  • In his former role as Minister of Health and Long Term Care for Ontario, Dr Hoskins was responsible for oversight of the province’s prescription drug programs and advocated for improved access to and affordability of prescription medications. These statements were made as a public official and not as a private citizen.
Ms. Mia Homsy 1.
No
2.1
No
2.2
No
2.3
Yes
3.1
No
3.2
No
3.3
No
4.
No

Comments:

  • Ms. Homsy is the director of l’Institut du Québec (IdQ), an economic research center that is a partnership between HEC Montréal and the Conference Board of Canada. It is financed by private investors and Quebec’s Ministry of Finance.
  • In 2016, the IdQ undertook a contract for Janssen Pharmaceuticals; Ms. Homsy was not involved in this project.
Ms. Nadine Caron 1.
No

2.1
Yes

2.2
No
2.3
No
3.1
Yes
3.2
Yes
3.3
Yes
4.
No

Comments:

  • Dr. Caron is employed as a consultant for British Columbia’s First Nations Health Authority regarding health issues separate from pharmacare.
  • Dr. Caron was a reference group member for the External Review of the Pan-Canadian Health Organizations (2017-18).
  • In 2018, she was an author on a Lancet article on Canada’s health care system that mentioned pharmacare.
  • Dr. Caron has professional affiliations with the Canadian Medical Association, the Royal College of Physicians and Surgeons of Canada, Doctors of BC and the First Nations Health Authority.
Mr. Vincent Dumez 1.
Yes
2.1
No
2.2
No
2.3
Yes
3.1
No
3.2
No
3.3
Yes
4.
No

Comments:

  • Mr. Dumez’s wife is currently employed by a credit union that sells insurance products.
  • Mr. Dumez’s team at the Center of Excellence with Patients and the Public at the University of Montreal works with the Régie de l'Assurance Maladie du Québec as part of the deployment of the Quebec Health Booklet.
  • Mr. Dumez is a member of the Board of Directors of the World Federation of Hemophilia and is the Chair of its Education Advisory Committee. 
Ms. Camille Orridge 1.
No
2.1
No
2.2
No
2.3
No
3.1
No
3.2
No
3.3
Yes
4.
No

Comments:

  • Ms. Orridge sits on the board of Health Quality Ontario.
Hon. Diana Whalen 1.
No
2.1
No
2.2
No
2.3
No
3.1
No
3.2
No
3.3
No
4.
No

Comments:

  • The Hon. Diana Whalen was a member of the Nova Scotia House of Assembly from 2003 to 2017 and was the Minister of Finance (2013-2015), Minister of Justice (2015-2017) and Deputy Premier (2013-2017) during that time. While in these roles she did not participate in any activities of relevance to the mandate of the Council.
Mr. John Wright 1.
No
2.1
Yes
2.2
No
2.3
No
3.1
No
3.2
No
3.3
No
4.
No

Comments:

  • Mr. Wright was contracted by the Public Policy Forum to moderate two roundtable discussions on “Balancing Innovation, Affordability and Outcomes: A New Model for Accessing Innovative Drugs”.
  • From 2010 to 2014, he was the President and CEO of Canadian Institute for Health Information.

Page details

Date modified: